Advanced search
2 files | 1.37 MB Add to list

Phenotyping asthma with airflow obstruction in middle-aged and older adults : a CADSET clinical research collaboration

Author
Organization
Abstract
Background The prevalence and clinical profile of asthma with airflow obstruction (AO) remain uncertain. We aimed to phenotype AO in population- and clinic-based cohorts. Methods This cross-sectional multicohort study included adults = 50 years from nine CADSET cohorts with spirometry data (N=69 789). AO was defined as ever diagnosed asthma with pre-BD or post-BD FEV1/FVC <0.7 in population-based and clinic-based cohorts, respectively. Clinical characteristics and comorbidities of AO were compared with asthma without airflow obstruction (asthma-only) and chronic obstructive pulmonary disease (COPD) without asthma history (COPD-only). ORs for comorbidities adjusted for age, sex, smoking status and body mass index (BMI) were meta-analysed using a random effects model. Results The prevalence of AO was 2.1% (95% CI 2.0% to 2.2%) in population-based, 21.1% (95% CI 18.6% to 23.8%) in asthma-based and 16.9% (95% CI 15.8% to 17.9%) in COPD-based cohorts. AO patients had more often clinically relevant dyspnoea (modified Medical Research Council score >= 2) than asthma-only (+14.4 and +14.7 percentage points) and COPD-only (+24.0 and +5.0 percentage points) in population-based and clinic-based cohorts, respectively. AO patients had more often elevated blood eosinophil counts (>300 cells/mu L), although only significant in population-based cohorts. Compared with asthma-only, AO patients were more often men, current smokers, with a lower BMI, had less often obesity and had more often chronic bronchitis. Compared with COPD-only, AO patients were younger, less often current smokers and had less pack-years. In the general population, AO patients had a higher risk of coronary artery disease than asthma-only and COPD-only (OR=2.09 (95% CI 1.26 to 3.47) and OR=1.89 (95% CI 1.10 to 3.24), respectively) and of depression (OR=1.41 (95% CI 1.19 to 1.67)), osteoporosis (OR=2.30 (95% CI 1.43 to 3.72)) and gastro-oesophageal reflux disease (OR=1.68 (95% CI 1.06 to 2.68)) than COPD-only, independent of age, sex, smoking status and BMI. Conclusions AO is a relatively prevalent respiratory phenotype associated with more dyspnoea and a higher risk of coronary artery disease and elevated blood eosinophil counts in the general population compared with both asthma-only and COPD-only.
Keywords
Pulmonary and Respiratory Medicine, Clinical Epidemiology, Asthma, Pulmonary Disease, Chronic Obstructive, COPD epidemiology, Asthma Epidemiology

Downloads

  • e001760.full.pdf
    • full text (Published version)
    • |
    • open access
    • |
    • PDF
    • |
    • 737.51 KB
  • Supplementary Material.pdf
    • supplementary material
    • |
    • open access
    • |
    • PDF
    • |
    • 633.94 KB

Citation

Please use this url to cite or link to this publication:

MLA
Bertels, Xander, et al. “Phenotyping Asthma with Airflow Obstruction in Middle-Aged and Older Adults : A CADSET Clinical Research Collaboration.” BMJ OPEN RESPIRATORY RESEARCH, vol. 10, no. 1, BMJ, 2023, doi:10.1136/bmjresp-2023-001760.
APA
Bertels, X., Edris Mohamed, A., Garcia-Aymerich, J., Faner, R., Meteran, H., Sigsgaard, T., … Lahousse, L. (2023). Phenotyping asthma with airflow obstruction in middle-aged and older adults : a CADSET clinical research collaboration. BMJ OPEN RESPIRATORY RESEARCH, 10(1). https://doi.org/10.1136/bmjresp-2023-001760
Chicago author-date
Bertels, Xander, Ahmed Edris Mohamed, Judith Garcia-Aymerich, Rosa Faner, Howraman Meteran, Torben Sigsgaard, Peter Alter, et al. 2023. “Phenotyping Asthma with Airflow Obstruction in Middle-Aged and Older Adults : A CADSET Clinical Research Collaboration.” BMJ OPEN RESPIRATORY RESEARCH 10 (1). https://doi.org/10.1136/bmjresp-2023-001760.
Chicago author-date (all authors)
Bertels, Xander, Ahmed Edris Mohamed, Judith Garcia-Aymerich, Rosa Faner, Howraman Meteran, Torben Sigsgaard, Peter Alter, Claus Vogelmeier, Nuria Olvera, Nazanin Zounemat Kermani, Alvar Agusti, Gavin C Donaldson, Jadwiga A Wedzicha, Guy Brusselle, Helena Backman, Eva Rönmark, Anne Lindberg, Judith M Vonk, Kian Fan Chung, Ian M Adcock, Maarten van den Berge, and Lies Lahousse. 2023. “Phenotyping Asthma with Airflow Obstruction in Middle-Aged and Older Adults : A CADSET Clinical Research Collaboration.” BMJ OPEN RESPIRATORY RESEARCH 10 (1). doi:10.1136/bmjresp-2023-001760.
Vancouver
1.
Bertels X, Edris Mohamed A, Garcia-Aymerich J, Faner R, Meteran H, Sigsgaard T, et al. Phenotyping asthma with airflow obstruction in middle-aged and older adults : a CADSET clinical research collaboration. BMJ OPEN RESPIRATORY RESEARCH. 2023;10(1).
IEEE
[1]
X. Bertels et al., “Phenotyping asthma with airflow obstruction in middle-aged and older adults : a CADSET clinical research collaboration,” BMJ OPEN RESPIRATORY RESEARCH, vol. 10, no. 1, 2023.
@article{01H9J7PXXRK4T784F95QN0S5XJ,
  abstract     = {{Background The prevalence and clinical profile of asthma with airflow obstruction (AO) remain uncertain. We aimed to phenotype AO in population- and clinic-based cohorts.

Methods This cross-sectional multicohort study included adults = 50 years from nine CADSET cohorts with spirometry data (N=69 789). AO was defined as ever diagnosed asthma with pre-BD or post-BD FEV1/FVC <0.7 in population-based and clinic-based cohorts, respectively. Clinical characteristics and comorbidities of AO were compared with asthma without airflow obstruction (asthma-only) and chronic obstructive pulmonary disease (COPD) without asthma history (COPD-only). ORs for comorbidities adjusted for age, sex, smoking status and body mass index (BMI) were meta-analysed using a random effects model.

Results The prevalence of AO was 2.1% (95% CI 2.0% to 2.2%) in population-based, 21.1% (95% CI 18.6% to 23.8%) in asthma-based and 16.9% (95% CI 15.8% to 17.9%) in COPD-based cohorts. AO patients had more often clinically relevant dyspnoea (modified Medical Research Council score >= 2) than asthma-only (+14.4 and +14.7 percentage points) and COPD-only (+24.0 and +5.0 percentage points) in population-based and clinic-based cohorts, respectively. AO patients had more often elevated blood eosinophil counts (>300 cells/mu L), although only significant in population-based cohorts. Compared with asthma-only, AO patients were more often men, current smokers, with a lower BMI, had less often obesity and had more often chronic bronchitis. Compared with COPD-only, AO patients were younger, less often current smokers and had less pack-years. In the general population, AO patients had a higher risk of coronary artery disease than asthma-only and COPD-only (OR=2.09 (95% CI 1.26 to 3.47) and OR=1.89 (95% CI 1.10 to 3.24), respectively) and of depression (OR=1.41 (95% CI 1.19 to 1.67)), osteoporosis (OR=2.30 (95% CI 1.43 to 3.72)) and gastro-oesophageal reflux disease (OR=1.68 (95% CI 1.06 to 2.68)) than COPD-only, independent of age, sex, smoking status and BMI.

Conclusions AO is a relatively prevalent respiratory phenotype associated with more dyspnoea and a higher risk of coronary artery disease and elevated blood eosinophil counts in the general population compared with both asthma-only and COPD-only.}},
  articleno    = {{e001760}},
  author       = {{Bertels, Xander and Edris Mohamed, Ahmed and Garcia-Aymerich, Judith and Faner, Rosa and Meteran, Howraman and Sigsgaard, Torben and Alter, Peter and Vogelmeier, Claus and Olvera, Nuria and Kermani, Nazanin Zounemat and Agusti, Alvar and Donaldson, Gavin C and Wedzicha, Jadwiga A and Brusselle, Guy and Backman, Helena and Rönmark, Eva and Lindberg, Anne and Vonk, Judith M and Chung, Kian Fan and Adcock, Ian M and van den Berge, Maarten and Lahousse, Lies}},
  issn         = {{2052-4439}},
  journal      = {{BMJ OPEN RESPIRATORY RESEARCH}},
  keywords     = {{Pulmonary and Respiratory Medicine,Clinical Epidemiology,Asthma,Pulmonary Disease, Chronic Obstructive,COPD epidemiology,Asthma Epidemiology}},
  language     = {{eng}},
  number       = {{1}},
  pages        = {{9}},
  publisher    = {{BMJ}},
  title        = {{Phenotyping asthma with airflow obstruction in middle-aged and older adults : a CADSET clinical research collaboration}},
  url          = {{http://doi.org/10.1136/bmjresp-2023-001760}},
  volume       = {{10}},
  year         = {{2023}},
}

Altmetric
View in Altmetric
Web of Science
Times cited: